Aims : to provide the audience with updates on the pathogenesis, epidemiology and pharmacological and nonpharmacological management of dyspnoea, cough and fatigue in ILD; to learn about the impact of these symptoms on general and emotional well-being and daily activities of the patient; to provide an overview of the most common and burdensome symptoms in patients with ILD; toupdatd on the most recent scientific evidence with regards to the pathophysiology and management of dyspnoea, cough and fatigue, and their impact on patients.